<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03245866</url>
  </required_header>
  <id_info>
    <org_study_id>SwissSOS_0001</org_study_id>
    <nct_id>NCT03245866</nct_id>
  </id_info>
  <brief_title>Swiss Study on Subarachnoid Hemorrhage</brief_title>
  <acronym>Swiss SOS</acronym>
  <official_title>Swiss Study on Subarachnoid Hemorrhage (Swiss SOS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Bern</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kantonsspital Aarau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale Regionale di Lugano</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, ZÃ¼rich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cantonal Hospital of St. Gallen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This registry was created to assess management parameters of patients treated for aneurysmal
      subarachnoid hemorrhage in Switzerland. All Swiss hospitals with a neurosurgery department,
      an intensive care unit and an interventional neuroradiology team that treat neurovascular
      emergencies participate in the registry. Clinical parameters are entered into a common
      database. This database will provide (1) a nationwide assessment of the current standard of
      care and (2) the outcomes for patients in Switzerland including neuropsychological
      assessments.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Overview:

      The management of aneurysmal subarachnoid hemorrhage (aSAH) in Switzerland has not been
      assessed on a national level to date. The investigators united all comprehensive
      neurovascular care centres in Switzerland to create a registry for aSAH. This registry helps
      collect clinical and management data from different centres and pools it in one common
      database. It may provide referring caregivers and healthcare providers with a critical tool
      to assess the quality of care in a disease which has a high socio-economic burden. Moreover,
      it may serve as a tool to foster scientific collaboration and address a number of remaining
      questions about the management of aSAH in the future. Regarding SAH, data from the federal
      statistics bureau of Switzerland are based strictly on ICD-10 codes provided by hospitals and
      show an estimate of 13 per 100,000 in a population of roughly 8 million
      (http://bfs.admin.ch). These numbers, however, are not referring to aneurismal SAH
      exclusively and thus exceed the numbers which the investigators expect to obtain. The goal is
      to obtain complete recruitment of SAH patients throughout Switzerland, and the goal is
      therefore that assessment of incidence will be performed later on.

      Data management:

      Data is entered into a central online database created by the Secutrial platform. This
      platform is provided by the University Hospital of Geneva's Clinical Research Unit. The
      database disposes of an audit-trail capacity. Local principal investigators are responsible
      for data-cross check and quality management. Source data verification is performed by
      investigators on site who address missing data. Regular meetings are held to discuss data
      patency.

      The platform automatically provides a report on recruitment progress.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2009</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Functional outcome as assessed by the modified Rankin scale</measure>
    <time_frame>5 years after hemorrhage</time_frame>
    <description>The modified Rankin scale is used to represent the level of disability and is divided into 7 categories (0-6). The scale runs from 0-6, running from perfect health without symptoms to death.
0 - No symptoms.
- No significant disability. Able to carry out all usual activities, despite some symptoms.
- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities.
- Moderate disability. Requires some help, but able to walk unassisted.
- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted.
- Severe disability. Requires constant nursing care and attention, bedridden, incontinent.
- Dead.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Subarachnoid Hemorrhage</condition>
  <condition>Intracranial Aneurysm</condition>
  <arm_group>
    <arm_group_label>Aneurysmal Subarachnoid hemorrhage</arm_group_label>
    <description>Patients suffering from a ruptured cerebral aneurysm are included in the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational/ no intervention</intervention_name>
    <arm_group_label>Aneurysmal Subarachnoid hemorrhage</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients admitted in Switzerland with a diagnosis of aneurysmal subarachnoid hemorrhage
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

        - Patients admitted with a proven diagnosis of aneurysmal subarachnoid hemorrhage.

        Exclusion criteria:

        - Patients in whom the source of haemorrhage could not be identified (angiogram-negative
        SAH) or SAH with other causes than cerebral aneurysms.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karl Schaller, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Geneva</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bawarjan Schatlo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Geneva</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin N Stienen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Geneva</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karl Schaller, MD</last_name>
    <phone>+41223728202</phone>
    <email>karl.schaller@hcuge.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bawarjan Schatlo, MD</last_name>
    <phone>+491791226047</phone>
    <email>bawarjan.schatlo@med.uni-goettingen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kantonsspital Aarau</name>
      <address>
        <city>Aarau</city>
        <state>Aargau</state>
        <zip>5000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali-Reza Fathi, MD</last_name>
      <email>ali-reza.fathi@ksa.ch</email>
    </contact>
    <contact_backup>
      <last_name>Javier Fandino, MD</last_name>
      <email>javier.fandino@ksa.ch</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Geneva University Hospital</name>
      <address>
        <city>Geneva</city>
        <state>GE</state>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl Schaller, MD</last_name>
      <phone>+41223728202</phone>
      <email>karl.schaller@hcuge.ch</email>
    </contact>
    <contact_backup>
      <last_name>Philippe Bijlenga, MD, PhD</last_name>
      <phone>+41223723246</phone>
      <email>philippe.bijlenga@hcuge.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Karl Schaller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin N Stienen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe Bijlenga, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bawarjan Schatlo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Zumofen, MD</last_name>
      <email>daniel.zumofen@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Michel Roethlisberger, MD</last_name>
      <email>coles@bluewin.ch</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University Hospital Bern</name>
      <address>
        <city>Bern</city>
        <zip>3000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Fung, MD</last_name>
      <email>christian.fung@insel.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Lausanne</name>
      <address>
        <city>Lausanne</city>
        <zip>1000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roy T Daniel, MD</last_name>
      <email>roy.daniel@chuv.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Civico</name>
      <address>
        <city>Lugano</city>
        <zip>6900</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Reinert, MD</last_name>
      <email>michael.reinert@eoc.ch</email>
    </contact>
    <contact_backup>
      <last_name>Daniel Valsecchi, MD</last_name>
      <email>daniele.valsecchi@eoc.ch</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Kantonsspital St. Gallen</name>
      <address>
        <city>St. Gallen</city>
        <zip>9000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Seule, MD</last_name>
      <email>martin.seule@kssg.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital ZÃ¼rich</name>
      <address>
        <city>ZÃ¼rich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emanuela Keller, MD</last_name>
      <email>emanuela.keller@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Jan-Karl Burkhardt, MD</last_name>
      <email>jan-karl.burkhardt@usz.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Zweifel-Zehnder AE, Stienen MN, Chicherio C, Studerus-Germann A, BlÃ¤si S, Rossi S, Gutbrod K, Schmid N, Beaud V, Mondadori C, Brugger P, Sacco L, MÃ¼ri R, Hildebrandt G, Fournier JY, Keller E, Regli L, Fandino J, Mariani L, Raabe A, Daniel RT, Reinert M, Robert T, Schatlo B, Bijlenga P, Schaller K, Monsch AU; Swiss SOS study group. Call for uniform neuropsychological assessment after aneurysmal subarachnoid hemorrhage: Swiss recommendations. Acta Neurochir (Wien). 2015 Sep;157(9):1449-58. doi: 10.1007/s00701-015-2480-y. Epub 2015 Jul 16.</citation>
    <PMID>26179382</PMID>
  </reference>
  <results_reference>
    <citation>Schatlo B, Fung C, Fathi AR, Sailer M, Winkler K, Daniel RT, Bijlenga P, Ahlborn P, Seule M, Zumofen D, Reinert M, Woernle C, Stienen M, Levivier M, Hildebrandt G, Mariani L, Bernays R, Fandino J, Raabe A, Keller E, Schaller K. Introducing a nationwide registry: the Swiss study on aneurysmal subarachnoid haemorrhage (Swiss SOS). Acta Neurochir (Wien). 2012 Dec;154(12):2173-8; discussion 2178. doi: 10.1007/s00701-012-1500-4. Epub 2012 Oct 6.</citation>
    <PMID>23053275</PMID>
  </results_reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2015</study_first_submitted>
  <study_first_submitted_qc>August 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2017</study_first_posted>
  <last_update_submitted>August 7, 2017</last_update_submitted>
  <last_update_submitted_qc>August 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Bawarjan Schatlo, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Subarachnoid Hemorrhage</keyword>
  <keyword>Intracranial Aneurysm</keyword>
  <keyword>Ruptured Intracranial Aneurysm</keyword>
  <keyword>Neurosurgery</keyword>
  <keyword>Interventional Neuroradiology</keyword>
  <keyword>Neurointensive Care Medicine</keyword>
  <keyword>Switzerland</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>N/A, observational study</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

